Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Cancer Prev Res (Phila). 2011 Dec 13;5(2):336–342. doi: 10.1158/1940-6207.CAPR-11-0426

Table 3.

Association of urinary PGE-M levels and colorectal adenoma risk, Tennessee Colorectal Polyp Study

Study Group PGE-M (quartile)
p for trend
Q1 (low) Q2 Q3 Q4
Polyp-Free Controls
 n 90 89 90 89
Any Advanced Adenoma
 n 26 51 76 69
 OR (95% CI) a 1.00 (reference) 1.64 (0.90–2.95) 2.42 (1.37–4.28) 2.17 (1.20–3.92) 0.006
 OR (95% CI) b 1.00 (reference) 1.56 (0.84–2.90) 2.25 (1.23–4.09) 1.84 (0.97–3.48) 0.04
Multiple Small Tubular Adenoma
 n 16 36 44 52
 OR (95% CI) a 1.00 (reference) 2.13 (1.02–4.44) 2.13 (1.03–4.40) 2.57 (1.24–5.34) 0.03
 OR (95% CI) b 1.00 (reference) 2.59 (1.20–5.60) 2.31 (1.07–5.00) 2.88 (1.32–6.24) 0.03
Single Small Tubular Adenoma
 n 66 80 73 79
 OR (95% CI) a 1.00 (reference) 1.14 (0.72–1.82) 0.99 (0.61–1.61) 1.11 (0.67–1.82) 0.87
 OR (95% CI) b 1.00 (reference) 1.16 (0.72–1.86) 0.93 (0.56–1.53) 1.04 (0.62–1.74) 0.88
Advanced or Multiple Adenoma
 n 42 87 120 121
 OR (95% CI) a 1.00 (reference) 1.84 (1.11–3.05) 2.32 (1.41–3.81) 2.34 (1.41–3.87) 0.001
 OR (95% CI) b 1.00 (reference) 1.95 (1.15–3.30) 2.31 (1.37–3.89) 2.19 (1.28–3.76) 0.008
a

Adjusted for age, gender, race, educational attainment, and study site

b

Additionally adjusted for cigarette smoking, alcohol consumption, BMI, red meat intake, and NSAID use